James S. Scibetta, SVP, Chief Financial Officer at Pacira Pharmaceuticals, Inc. (PCRX), sold 15,000 shares at $75.25 ($1.1M) on 2014-05-08, disclosed to the SEC on 2014-05-09.
Scheduled sale ($1.1M) by SVP, Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $74.27 | 3,300 | $245K | 21.8% |
| 2 | $75.25 | 11,400 | $858K | 76.2% |
| 3 | $75.80 | 300 | $23K | 2.0% |
| Total | $75.05 avg | 15,000 | $1.1M | 100% |
| Filing → |
| PCRX | SELL | 2017-06-07 | $170K | — | Filing → |
| PCRX | SELL | 2017-05-17 | $1.0M | — | Filing → |
| PCRX | SELL | 2017-01-19 | $1.5M | — | Filing → |